BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity. Stansfield KH, Bichell TJ, Bowman AB, Guilarte TR (2014) J Neurochem 131: 655-66 Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. Yin Z, Jiang H, Lee ES, Ni M, Erikson KM, Milatovic D, Bowman AB, Aschner M (2010) J Neurochem 112: 1190-8 Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia. Stanwood GD, Leitch DB, Savchenko V, Wu J, Fitsanakis VA, Anderson DJ, Stankowski JN, Aschner M, McLaughlin B (2009) J Neurochem 110: 378-89 Manganese homeostasis in the nervous system. Chen P, Chakraborty S, Mukhopadhyay S, Lee E, Paoliello MM, Bowman AB, Aschner M (2015) J Neurochem 134: 601-10 Considerations on manganese (Mn) treatments for in vitro studies. Bowman AB, Aschner M (2014) Neurotoxicology 41: 141-2 The use of magnetic resonance imaging (MRI) in the study of manganese neurotoxicity. Fitsanakis VA, Zhang N, Avison MJ, Gore JC, Aschner JL, Aschner M (2006) Neurotoxicology 27: 798-806 Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects. Aboud AA, Tidball AM, Kumar KK, Neely MD, Ess KC, Erikson KM, Bowman AB (2012) Neurotoxicology 33: 1443-1449 Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features. Kwakye GF, Paoliello MM, Mukhopadhyay S, Bowman AB, Aschner M (2015) Int J Environ Res Public Health 12: 7519-40 Differential deposition of manganese in the rat brain following subchronic exposure to manganese: a T1-weighted magnetic resonance imaging study. Finkelstein Y, Zhang N, Fitsanakis VA, Avison MJ, Gore JC, Aschner M (2008) Isr Med Assoc J 10: 793-8
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.